Literature DB >> 2106591

Update on chronic granulomatous diseases of childhood. Immunotherapy and potential for gene therapy.

J I Gallin1, H L Malech.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2106591

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

1.  Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease.

Authors:  H L Malech; P B Maples; N Whiting-Theobald; G F Linton; S Sekhsaria; S J Vowells; F Li; J A Miller; E DeCarlo; S M Holland; S F Leitman; C S Carter; R E Butz; E J Read; T A Fleisher; R D Schneiderman; D E Van Epps; S K Spratt; C A Maack; J A Rokovich; L K Cohen; J I Gallin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

2.  Bone marrow transplantation in chronic granulomatous disease.

Authors:  M C Calviño; M S Maldonado; E Otheo; A Muñoz; J M Couselo; C Burgaleta
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

3.  Cloning and functional expression of the mouse homologue of p47phox.

Authors:  S H Jackson; H L Malech; C A Kozak; K J Lomax; J I Gallin; S M Holland
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

4.  The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort.

Authors:  K F Heim; T A Fleisher; D F Stroncek; S M Holland; J I Gallin; H L Malech; S F Leitman
Journal:  Transfusion       Date:  2010-12-22       Impact factor: 3.157

5.  Peripheral blood progenitors as a target for genetic correction of p47phox-deficient chronic granulomatous disease.

Authors:  S Sekhsaria; J I Gallin; G F Linton; R M Mallory; R C Mulligan; H L Malech
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

Review 6.  Interferon gamma-1b. A review of its pharmacology and therapeutic potential in chronic granulomatous disease.

Authors:  P A Todd; K L Goa
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

7.  A case of selective immunoglobulin M deficiency and autoimmune glomerulonephritis.

Authors:  Marina Antar; Jorge Lamarche; Alfredo Peguero; Alexander Reiss; Steven Cole
Journal:  Clin Exp Nephrol       Date:  2008-03-26       Impact factor: 2.801

Review 8.  Chronic granulomatous disease 100% corrected by displacement bone marrow transplantation from a volunteer unrelated donor.

Authors:  J R Hobbs; M Monteil; D R McCluskey; E Jurges; M el Tumi
Journal:  Eur J Pediatr       Date:  1992-11       Impact factor: 3.183

Review 9.  Chronic granulomatous disease and other disorders of neutrophil function.

Authors:  N R Kamani; A J Infante
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 10.817

10.  The p47phox mouse knock-out model of chronic granulomatous disease.

Authors:  S H Jackson; J I Gallin; S M Holland
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.